Welcome to our dedicated page for NUSATRIP SEC filings (Ticker: NUTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NUSATRIP's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NUSATRIP's regulatory disclosures and financial reporting.
The Board and the Majority Stockholder approved the issuance of 75,000 shares of newly designated Series X Super Voting Preferred Stock to SOPA Capital Limited at a price of $7.50 per share, with each preferred share carrying 1,000 votes.
The Series X shares are non‑convertible, carry no dividend or liquidation preference and have no redemption or sunset provisions. The Board unanimously approved the Stock Issuance on February 26, 2026, the Majority Stockholder consent (representing ~61% of voting power) was given, and the action becomes effective at least 20 calendar days after mailing.
NusaTrip Incorporated reports that trading of its common stock on the Nasdaq Stock Market remains halted while U.S. regulators review information about the company and its securities. Nasdaq requested information starting October 9, 2025, and the company sent follow-up responses on November 17, 2025.
On December 22, 2025, the U.S. Securities and Exchange Commission asked NusaTrip for the voluntary production of documents, and the company responded on January 20, 2026. NusaTrip states it is fully cooperating with both Nasdaq and the SEC and says its daily business operations remain normal and not materially affected by the trading suspension.
Nusatrip Incorporated reported Q3 performance showing rapid revenue growth but continued losses. Total revenue was $768,674 for the three months ended September 30, 2025, up from $173,446 a year earlier, driven mainly by online ticketing ($563,150) and online advertising ($200,000). For the nine months, revenue reached $2,044,872 versus $887,711 in 2024. Net loss attributable to the company was $963,690 in Q3 and $579,579 year‑to‑date, as higher general and administrative expenses offset gross profit and other income.
The balance sheet strengthened materially through equity issuance. Shareholders’ equity improved to $10,626,539 at September 30, 2025 from a deficit of $(5,828,060) at December 31, 2024, with additional paid‑in capital rising to $18,896,252. Cash and cash equivalents were $5,104,182 at quarter‑end. Operating cash outflow was $(18,473,804) for the nine months, largely funded by $16,920,361 of financing inflows, including $16,804,321 from share issuances. Common shares outstanding were 19,379,168 as of November 14, 2025.
NusaTrip (NUTR) announced a leadership change. Effective November 1, 2025, Anson Neo was appointed Chief Executive Officer. He had served as Chief Marketing Officer since August 2023 and brings experience from airlines, GDSs, and major OTAs across Southeast Asia and Greater China. The company does not intend to appoint a replacement CMO at this time.
Tjin Patrick Soetanto was redesignated as Head of Hotel and will no longer serve as CEO. The company stated his redesignation was not due to any disagreement. The Board is determining any changes to Mr. Neo’s compensation, with any material terms to be disclosed by amendment.
NusaTrip Incorporated reported that the U.S. SEC ordered a temporary suspension of trading in its securities from 4:00 a.m. ET on October 9, 2025 through 11:59 p.m. ET on October 22, 2025. The order is posted on the SEC’s trading suspensions page.
On October 9, 2025, Nasdaq requested certain information and documents from the company. NusaTrip stated it will fully cooperate with both the SEC and Nasdaq.
NusaTrip Incorporated reported that the underwriters in its recent initial public offering fully exercised their over-allotment option. On September 5, 2025, the company issued and sold 562,500 shares of common stock at $4.00 per share, generating additional gross proceeds of approximately $2,250,000.
Including this over-allotment exercise, NusaTrip has now raised aggregate gross proceeds of $17,250,000 in its IPO, before underwriting discounts, commissions and offering expenses. The additional capital strengthens the company’s cash position following its Nasdaq listing, while modestly increasing its total shares sold to public investors through the IPO process.
Nusatrip Incorporated (NUTR) filed a Form 10-Q showing mixed interim results and liquidity strain. The filing reports a net profit of $997,691 for a presented period and a net loss of $(436,611) for a comparative period, with revenue streams dominated by online advertising of $557,103. Cash and cash equivalents were reported at $6,924,437, but management disclosed a working capital deficit of $3,826,974 and accumulated deficits of $5,908,407, which the company says raise substantial doubt about its ability to continue as a going concern. Operating activities used $1,506,976 of cash, while the company recorded proceeds from issuance of shares of $1,600,002. Other disclosed items include cost and gross income line items, related party balances, lease liabilities (present value $97,801), intangible and property balances, and deferred tax valuation allowances.